Serum 2′,5′‐oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B
Michiko Shindo, Tadao Okuno, Masayuki Matsumoto, Makoto Takeda, Tatsuro Takino, Junko Sokawa, Akira Iwata, Yoshihiro Sokawa – 1 March 1988 – We measured 2′,5′‐oligoadenylate synthetase activities in serum and peripheral blood mononuclear cells from 10 patients with chronic hepatitis B who were being treated with interferon so as to determine whether 2′,5′‐oligoadenylate synthetase activity in serum reflected 2′,5′‐oligoadenylate synthetase activity in peripheral blood mononuclear cells, and whether it could be used to monitor interferon treatment.